Trial · NCT04958785
Participant flow15
How many started, completed or left each group, period by period.
1 to 15 of 15
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Safety Run-in Cohort 1: Magrolimab + Nab-Paclitaxel | 8 | |
| Overall Study | STARTED | Phase 2 Cohort 1 Arm A: Magrolimab + Nab-Paclitaxel or Paclitaxel | 14 | |
| Overall Study | STARTED | Phase 2 Cohort 1 Arm B: Nab-Paclitaxel or Paclitaxel | 14 | |
| Overall Study | STARTED | Safety Run-in Cohort 2: Magrolimab + Sacituzumab Govitecan | 13 | |
| Overall Study | STARTED | Phase 2 Cohort 2: Magrolimab + Sacituzumab Govitecan | 43 | |
| Overall Study | COMPLETED | Safety Run-in Cohort 1: Magrolimab + Nab-Paclitaxel | 0 | |
| Overall Study | COMPLETED | Phase 2 Cohort 1 Arm A: Magrolimab + Nab-Paclitaxel or Paclitaxel | 0 | |
| Overall Study | COMPLETED | Phase 2 Cohort 1 Arm B: Nab-Paclitaxel or Paclitaxel | 0 | |
| Overall Study | COMPLETED | Safety Run-in Cohort 2: Magrolimab + Sacituzumab Govitecan | 0 | |
| Overall Study | COMPLETED | Phase 2 Cohort 2: Magrolimab + Sacituzumab Govitecan | 0 | |
| Overall Study | NOT COMPLETED | Safety Run-in Cohort 1: Magrolimab + Nab-Paclitaxel | 8 | |
| Overall Study | NOT COMPLETED | Phase 2 Cohort 1 Arm A: Magrolimab + Nab-Paclitaxel or Paclitaxel | 14 | |
| Overall Study | NOT COMPLETED | Phase 2 Cohort 1 Arm B: Nab-Paclitaxel or Paclitaxel | 14 | |
| Overall Study | NOT COMPLETED | Safety Run-in Cohort 2: Magrolimab + Sacituzumab Govitecan | 13 | |
| Overall Study | NOT COMPLETED | Phase 2 Cohort 2: Magrolimab + Sacituzumab Govitecan | 43 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04958785/flow